Dr Thomas Andrew, F. Hoffmann-La Roche AG, Basel
| Start Date | 28.02.2013 - 14:00 |
| Event End | 01.03.2013 - 15:00 |
| Location | Université de Genève |
Discovery of Bitopertin: A potent and selective GlyT1 inhibitor (GRI) for the treatment of Schizophrenia
| Start Date | 28.02.2013 - 14:00 |
| Event End | 01.03.2013 - 15:00 |
| Location | Université de Genève |
Discovery of Bitopertin: A potent and selective GlyT1 inhibitor (GRI) for the treatment of Schizophrenia